Background: Chronic myeloid leukemia (CML) treatment monitoring using PCR based peripheral blood testing provides improved test sensitivity over cytology but suffers from inadequate standardization due to variation inherent in the existing PCR methodologies. Standardized Nucleic Acid Quantification BCR-ABL (SNAQ-BCRABL) is a novel competitive template based peripheral blood b2a2/b3a2 transcript abundance method. It uses mixtures of b2a2 or b3a2 and GusB competitive templates and melting curve analysis to provide desired quality controls to correct for procedural variation. A pilot study was conducted in CML patients to evaluate the imprecision and linearity of two established real-time qPCR laboratory developed test (LDT) and SNAQ for monitoring BCR-ABL.
Imprecision was estimated using the Bland-Altman method and the plot indicated that sample results from L2 had 1 outlier, which was excluded from analysis. All three L1 difference plots (Fig.1B & C) had a significant trend (p<0.007), requiring regression correction prior to estimating variation. The linear regression analysis, indicated L2 LDT was a large source of method bias.
Post hoc analysis of method agreement showed the SNAQ method did not generate any outliers and had a 95% limit of agreement of ±3-fold between laboratories, whereas L1 and L2 LDT method had significant differences despite reporting in international scale, with 95% limit of agreement of 2 to 20-fold.
Conclusion:
In this pilot study, SNAQ methodology performed well suggesting it might be able to overcome some of the limitations encountered by some of the LDT currently in clinical practice. Additional studies with more patients and correlation with clinical outcomes are required to confirm this observation
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• CML treatment monitoring using PCR based peripheral blood testing provides improved test sensitivity over cytology but suffers from inadequate standardization in most labs due to variations, inherent in the existing PCR methodologies.
• Variable results in most labs are probably due to different techniques, internal controls, reagents, and methods of calculation
• We present the initial analytic performance evaluation of a novel competitive template based peripheral blood b2a2/b3a2 transcript abundance method.
• Standardized Nucleic Acid Quantification BCR-ABL (SNAQ-BCRABL) uses mixtures of b2a2 or b3a2 and GusB competitive templates and melting curve analysis to provide clinically needed quality controls to correct for operator, instrument, sample, and reagent variation when measuring transcript abundance.
• We hypothesized that the SNAQ-BCRABL method produced more consistent results with less frequent laboratory to laboratory variability.
SNAQ BCR-ABL work flow
The primary study goal required a >0.85 correlation between SNAQ and LDT was met with correlations of 0.96, 0.96, 0.97 and 0.94 with 1Lx2S, 2Lx2S, 1Sx1L and 2Sx2L respectively.
• Pilot study was conducted in CML patient to look at the imprecision and linearity of two established CLIA real-time qPCR assays and SNAQ-BCR ABL.
• Patients over 18 years of age, with known b2a2 or b3a2 allele of CML fusion, expected to be RT-qPCR positive for b2a2 and/or b3a2 (i.e., during their first year of CML therapy) were enrolled.
• Thirty six patients were enrolled in this pilot study. Blood was collected for RTqPCR and SNAQ method on the same day to be tested at the MD Anderson molecular diagnostic laboratory and another laboratory in New Jersey for BCR-ABL evaluation by RT-qPCR and SNAQ method simultaneously.
• SNAQ BCR-ABL pilot study met its primary concordance goal with established CLIA BCR-ABL monitoring tests.
• Post hoc analysis of method agreement showed the SNAQ method did not generate any outliers and had a 95% limit of agreement of ±3-fold between laboratories.
• The two LDT methods had significant differences despite reporting in international scale, with 95% limit of agreement of 2 to 20-fold.
• Additional studies with more patients and correlation with clinical outcomes are required to confirm this observation. • The SNAQ methods correlation between lab 1 and 2 was slightly better (1Sx2S, 0.88) than the LDT between two labs (1Lx2L, 0.86).
• 
